Upload Avatar (500 x 500)
Renxiao Wang
wangrx@fudan.edu.cn
Chinese, English
Shanghai
Fudan University
Pharmaceutical Sciences
  • 1989.09 – 1994.07 Bachelor of Science in Physical Chemistry: Peking University
  • 1994.09 – 1999.07 Doctor of Science in Physical Chemistry: Peking University
  • 1999.09 – 2000.08 Postdoctoral Research: University of California, Los Angeles
  • 2000.09 – 2001.08 Postdoctoral Research: Georgetown University Medical Center
  • Developed new theories and methods for molecular targeted drug design
  • Published over 140 SCI-indexed papers with over 13,400 Google citations (H-index 46)
  • Received over 40 national invention patents and software copyrights
  • 2001.09 – 2005.07 University of Michigan Medical School - Research Investigator
  • 2005.08 – 2019.12 Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences - Researcher
  • 2020.01 – Present Fudan University School of Pharmacy - Distinguished Researcher
  • WuXi AppTec 'Life Chemistry Research Award'
  • Chinese Chemical Society 'Young Computational Chemist Award'
  • Chinese Pharmaceutical Association 'Servier Young Medicinal Chemist Award'
  • 2012 International Society for Chemical Information 'Corwin Hansch Award'
  • 2017 National Natural Science Foundation of China 'National Outstanding Youth Science Fund Project'
Research and development of new theories and methods for molecular targeted drug design
Study of the mechanisms of action of important biological macromolecular systems or active small molecule compounds using molecular simulation techniques
Discovery and optimization of lead compounds for new targets using molecular design techniques to develop innovative drugs
  • Discovery of Small-Molecule Autophagy Inhibitors by Disrupting the Protein-Protein Interactions Involving ATG5, Xiang, H.; Liu, R.; Zhang, X.; An, R.; Zhou, M.; Tan, C.; Li, Q.; Su, M.; Guo, C.; Zhou, L.; Li, Y.; Wang, R. X., 2023
  • The potent BECN2-ATG14 coiled-coil interaction is selectively critical for endolysosomal degradation of GPRASP1/GASP1-associated GPCRs, Qiu, X. X.; Li, N.; Yang, Q. F.; Wu, S.; Li, X. H.; Pan, X. H.; Yamamoto, S.; Zhang, X. Z.; Zeng, J. C.; Liao, J. H.; He, C. C.; Wang, R. X.; Zhao, Y. X., 2023
  • HydraMap v.2: Prediction of Hydration Sites and Desolvation Energy with Refined Statistical Potentials, Li, Y.; Zhang, Z.; Wang, R. X., 2023
  • PLANET: A Multi-objective Graph Neural Network Model for Protein-Ligand Binding Affinity Prediction, Zhang, X. Y.; Gao, H. T.; Wang, H. J.; Chen, Z. H.; Zhang, Z.; Chen, X. C.; Li, Y.; Qi, Y. F.; Wang, R. X., 2023
  • Analysis of the Binding Sites on BAX and the Mechanism of BAX Activators Through Extensive Molecular Dynamics Simulations, Feng, G. Q.; Zhang, X. Y.; Li, Y.; Wang, R. X., 2022
  • Structure-Based Optimization of 3-phenyl-N-(2-(3-phenylureido)ethyl)thiophene-2-sulfonamide Derivatives as Selective Mcl-1 Inhibitors, Li, Y.; Fan, W. J.; Gong, Q. N.; Tian, J.; Zhou, M.; Li, Q.; Uwituze, L. B.; Zhang, Z. C.; Hong, R.; Wang, R. X., 2021
  • Optimization of Beclin 1-Targeting Stapled Peptides by Staple Scanning Leads to Enhanced Antiproliferative Potency in Cancer Cells, Yang, Q. F.; Qiu, X. X.; Zhang, X. Z.; Yu, Y. T.; Li, N.; Wei, X.; Feng, G. Q.; Li, Y.; Zhao, Y. X.; Wang, R. X., 2021
  • Revealing the Unbinding Kinetics and Mechanism of Type I and Type II Protein Kinase Inhibitors by Local-Scaled Molecular Dynamic Simulations, Du, Y.; Wang, R. X., 2020
  • Integration of Desolvation Effect into an Empirical Scoring Function, Li, Y.; Gao, Y. D.; Holloway, M. K.; Wang, R. X., 2020
  • Fragment-Based Computational Method for Designing GPCR Ligands, Li, Y.; Sun, Y. P.; Song, Y. P.; Dai, D. C.; Zhao, Z. X.; Zhang, Q.; Zhong, W. G.; Hu, L. Y.; Ma, Y. L.; Li, X.; Wang, R. X., 2020
  • Tapping on the Black Box: How is the Scoring Power of a Machine-Learning Scoring Function Depended on the Training Set?, Su, M. Y.; Feng, G. Q.; Liu, Z. H.; Li, Y.; Wang, R. X., 2020
  • Revisiting the Relationship Between Correlation Coefficient, Confidence Level, and Sample Size, Yang, Q. F.; Su, M. Y.; Li, Y.; Wang, R. X., 2019
  • Comparative Assessment of Scoring Functions: The CASF-2016 Update, Su, M. Y.; Yang, Q. F.; Du, Y.; Feng, G. Q.; Liu, Z. H.; Li, Y.; Wang, R. X., 2019
  • Assessing Protein-Ligand Interaction Scoring Functions with the CASF-2013 Benchmark, Li, Y.; Su, M. Y.; Liu, Z. H.; Li, J.; Liu, J.; Han, L.; Wang, R. X., 2018
  • 2-Aminoethoxydiphenylborane sensitizes anti-tumor effect of bortezomib via suppression of calcium-mediated autophagy, Qu, Y.-Q.; Gordillo-Martinez, F.; Law, B. Y. K.; Han, Y. Wu, A.-G.; Zeng, W.; Lam, W.-K.; Ho, C.; Mok, S. W. F.; He, H.-Q.; Wong, V. K. W.; Wang, R. X., 2018
  • Forging the Basis for Developing Protein−Ligand Interaction Scoring Functions, Liu, Z. H.; Su, M. Y.; Han, Li.; Liu, J.; Yang, Q. F.; Li, Y.; Wang, R.-X., 2017
Molecular Targeted Drug Design New Theories New Methods Molecular Simulation Biological Macromolecules Active Small Molecules Mechanisms Of Action Lead Compounds New Targets Innovative Drugs

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.